PURPOSE OF REVIEW: This article reviews two of the primary progressive aphasias (PPAs), disorders characterized by the early and predominant impairment of language, and primary progressive apraxia of speech, a degenerative motor speech disorder that is closely related to PPA. An outline of the history and controversy surrounding how these disorders are classified is provided before the article focuses on each disorder's clinical and imaging features. RECENT FINDINGS: Over the past decade, the classification of degenerative speech and language disorders has been refined. Clinical, imaging, and pathologic evidence suggests that primary progressive apraxia of speech is a distinct degenerative disorder. Furthermore, multiple lines of evidence have highlighted issues with nonfluent/agrammatic variant PPA, which complicates the diagnosis, prognosis, and study of this disorder. Semantic variant PPA, while not without controversy, remains one of the most well-defined disorders, with good clinicopathologic correlation. SUMMARY: Accurate classification and diagnosis of these degenerative speech and language disorders is crucial in clinical practice and ongoing research efforts. For nonfluent/agrammatic variant PPA, the authors suggest emphasizing agrammatism as the core inclusion criterion and taking care not to include patients with isolated or predominant apraxia of speech. Isolated apraxia of speech can be the manifestation of a degenerative disease and, based on the different prognosis, should be recognized as distinct from PPA. Finally, it is important to recognize that some patients with semantic dementia, despite sharing the same pathologic associations, may not meet criteria for PPA.
PURPOSE OF REVIEW: This article reviews two of the primary progressive aphasias (PPAs), disorders characterized by the early and predominant impairment of language, and primary progressive apraxia of speech, a degenerative motor speech disorder that is closely related to PPA. An outline of the history and controversy surrounding how these disorders are classified is provided before the article focuses on each disorder's clinical and imaging features. RECENT FINDINGS: Over the past decade, the classification of degenerative speech and language disorders has been refined. Clinical, imaging, and pathologic evidence suggests that primary progressive apraxia of speech is a distinct degenerative disorder. Furthermore, multiple lines of evidence have highlighted issues with nonfluent/agrammatic variant PPA, which complicates the diagnosis, prognosis, and study of this disorder. Semantic variant PPA, while not without controversy, remains one of the most well-defined disorders, with good clinicopathologic correlation. SUMMARY: Accurate classification and diagnosis of these degenerative speech and language disorders is crucial in clinical practice and ongoing research efforts. For nonfluent/agrammatic variant PPA, the authors suggest emphasizing agrammatism as the core inclusion criterion and taking care not to include patients with isolated or predominant apraxia of speech. Isolated apraxia of speech can be the manifestation of a degenerative disease and, based on the different prognosis, should be recognized as distinct from PPA. Finally, it is important to recognize that some patients with semantic dementia, despite sharing the same pathologic associations, may not meet criteria for PPA.
Authors: Keith A Josephs; Joseph R Duffy; Edythe A Strand; Mary M Machulda; Matthew L Senjem; Val J Lowe; Clifford R Jack; Jennifer L Whitwell Journal: Neurology Date: 2013-06-26 Impact factor: 9.910
Authors: Keith A Josephs; Joseph R Duffy; Edythe A Strand; Mary M Machulda; Matthew L Senjem; Jeffrey L Gunter; Christopher G Schwarz; Robert I Reid; Anthony J Spychalla; Val J Lowe; Clifford R Jack; Jennifer L Whitwell Journal: Brain Date: 2014-08-11 Impact factor: 13.501
Authors: Jennifer L Whitwell; Joseph R Duffy; Edythe A Strand; Mary M Machulda; Nirubol Tosakulwong; Stephen D Weigand; Matthew L Senjem; Anthony J Spychalla; Jeffrey L Gunter; Ronald C Petersen; Clifford R Jack; Keith A Josephs Journal: J Neurol Date: 2015-06-17 Impact factor: 4.849
Authors: Rene L Utianski; Joseph R Duffy; Heather M Clark; Edythe A Strand; Hugo Botha; Christopher G Schwarz; Mary M Machulda; Matthew L Senjem; Anthony J Spychalla; Clifford R Jack; Ronald C Petersen; Val J Lowe; Jennifer L Whitwell; Keith A Josephs Journal: Brain Lang Date: 2018-07-04 Impact factor: 2.381
Authors: Hugo Botha; Joseph R Duffy; Edythe A Strand; Mary M Machulda; Jennifer L Whitwell; Keith A Josephs Journal: Neurology Date: 2014-04-11 Impact factor: 9.910
Authors: John R Hodges; Jo Mitchell; Kate Dawson; Maria Grazia Spillantini; John H Xuereb; Paul McMonagle; Peter J Nestor; Karalyn Patterson Journal: Brain Date: 2009-10-05 Impact factor: 13.501
Authors: Christopher B Morrow; Jeannie-Marie Sheppard Leoutsakos; Chiadi U Onyike Journal: Am J Geriatr Psychiatry Date: 2021-07-28 Impact factor: 7.996
Authors: Maria Teresa Carthery-Goulart; Rosimeire de Oliveira; Isabel Junqueira de Almeida; Aline Campanha; Dayse da Silva Souza; Yossi Zana; Paulo Caramelli; Thais Helena Machado Journal: Front Neurol Date: 2022-05-16 Impact factor: 4.086
Authors: Rene L Utianski; Heather M Clark; Joseph R Duffy; Hugo Botha; Jennifer L Whitwell; Keith A Josephs Journal: Am J Speech Lang Pathol Date: 2020-08-05 Impact factor: 2.408
Authors: Angelina J Polsinelli; Mary M Machulda; Peter R Martin; Joseph R Duffy; Heather M Clark; Alissa M Butts; Hugo Botha; Val J Lowe; Jennifer L Whitwell; Keith A Josephs; Rene L Utianski Journal: J Int Neuropsychol Soc Date: 2021-07-22 Impact factor: 3.114
Authors: Jara Stalpaert; Marijke Miatton; Anne Sieben; Tim Van Langenhove; Pieter van Mierlo; Miet De Letter Journal: Front Hum Neurosci Date: 2021-06-02 Impact factor: 3.169